TrialBritish journal of cancer2015

Evaluation of efficacy and safety markers in a phase II study of metastatic colorectal cancer treated with aflibercept in the first-line setting.

Diether Lambrechts et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.